Marathon Digital Holdings Inc vs Organon & Co. Common Stock — how do they compare? Marathon Digital Holdings Inc trades at $8.09 (market cap $3.52B), while Organon & Co. Common Stock trades at $13.58 (market cap $3.62B). The key difference: Marathon Digital Holdings Inc and Organon & Co. Common Stock are close in size by market cap, and Organon & Co. Common Stock pays a 0.58% dividend while Marathon Digital Holdings Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Marathon Digital Holdings Inc for 22 Days and Organon & Co. Common Stock for 0 Days on average.
| MARA | OGN | |
|---|---|---|
Market Cap | $3.52B | $3.62B |
Volume | 36,018,511 | 2,892,999 |
Sector | Financials | Health |
52-Week High | $22.84 | $13.81 |
52-Week Low | $6.73 | $5.70 |
Typical Hold Time | 22 Days | 0 Days |
Enterprise Value | $5.56B | $11.04B |
Dividend Yield | — | 0.58% |
Signals from Pluang's Aura AI — not financial advice
Marathon Digital Holdings (MARA) trades at $9.11, down 3.5% on the day, reflecting ongoing volatility amid mixed technical signals. The stock shows bearish momentum in moving averages but bullish oscillators, with key resistance at $10. Fundamentally, the company reported significant losses with a net income margin of -429.71% in 2026, though valuation ratios appear attractive with P/E of 3.37. Recent news highlights continued analyst coverage and Bitcoin-related sector movements influencing stock performance.
MARA presents a high-risk opportunity with analyst consensus price target of $13 offering 43% upside potential, balanced by 45% buy and 45% hold ratings. However, persistent negative earnings, cash flow challenges, and Bitcoin market dependency create substantial risk. Investors must weigh the discounted valuation against the company's inability to achieve profitability despite revenue generation.
Organon (OGN) trades at $13.77, showing no change in the latest session. The stock demonstrates strong profitability with 52.68% gross margins and 24.04% ROE, though recent quarterly earnings have missed expectations. Valuation appears reasonable with P/E of 17.65 and P/S of 0.59. The company shows positive cash flow trends with 2026 projections indicating $533M net cash flow. Recent FDA developments for MIUDELLA and VTAMA products highlight ongoing pipeline progress.
OGN presents a mixed outlook with solid fundamentals offset by earnings misses. The healthcare company's improving cash flow and product pipeline offer potential upside, but investor sentiment remains divided with analysts showing cautious optimism. Key risks include execution challenges and competitive pressures in the pharmaceutical sector.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Marathon Digital Holdings, Inc. is one of the largest publicly traded Bitcoin mining companies in North America. The company focuses on building and operating large-scale, cost-efficient Bitcoin mining facilities. Marathon's strategy centers on increasing its mining hash rate and using sustainable energy sources to expand its Bitcoin production. The company's performance is closely tied to the price of Bitcoin and the overall health of the digital asset mining industry.
Read more on MARA →Organon & Co. is a global healthcare company focused on women's health, biosimilars, and established brands, spun off from Merck & Co. in 2021. Its portfolio of more than 70 medicines includes contraception and fertility therapies, immunology and oncology biosimilars, and treatments in cardiovascular, respiratory, and dermatology, distributed in over 140 countries.
Read more on OGN →